Invitae News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.02.19	Ausblick: Invitae legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
05.11.18	Ausblick: Invitae gewährt Anlegern Blick in die Bücher (finanzen.net)
20.09.18	UBX To Report Phase I Data In Q1, NVTA On Watch, NTGN Faces Busy Year Ahead (RTTNews)
13.06.18	Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing (PR Newswire)
30.05.18	Invitae to Present at the William Blair 2018 Growth Stock Conference (PR Newswire)
24.05.18	Quick Base and Workato Expand Strategic Partnership to Bolster No-Code Workflows in the Enterprise (PR Newswire)
10.05.18	FDA Snubs LPCN Again, NVTA Boosts Revenue Outlook, New Lease Of Life For VTVT (RTTNews)
09.05.18	Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018 (PR Newswire)
07.05.18	Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy (PR Newswire)
03.05.18	Invitae to participate in two upcoming investor conferences, the Bank of America Merrill Lynch 2018 Heath Care Conference and the UBS Global Healthcare Conference (PR Newswire)
27.04.18	Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA) (PR Newswire)
25.04.18	Invitae to Announce First Quarter 2018 Financial Results on May 9, 2018 (PR Newswire)
10.04.18	Invitae research highlights utility of proactive genetic screening, importance of assessing secondary findings in genetic testing (PR Newswire)
22.03.18	Invitae expands network of patients in rare and ultra-rare diseases (PR Newswire)
16.03.18	Invitae partners with KEW, Inc. to develop somatic mutation detection capabilities to improve cancer care by providing comprehensive genomic information (PR Newswire)
27.02.18	Invitae expands existing credit facility to provide up to $40.0 million in available growth capital (PR Newswire)
26.02.18	Invitae to present at the Cowen and Company 38th Annual Health Care Conference (PR Newswire)
12.02.18	Invitae reports over 150% volume and over 170% revenue growth for 2017 (PR Newswire)
31.01.18	Invitae to participate in two upcoming investor conferences, including the 2018 BIO CEO & Investor Conference and Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
29.01.18	Invitae to announce fourth quarter and year-end 2017 financial results on February 12, 2018 (PR Newswire)
08.01.18	Invitae more than doubles annual volume, exceeds full-year 2017 guidance, and projects momentum to continue in 2018 (PR Newswire)
05.12.17	Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families (PR Newswire)
15.11.17	Invitae Completes Acquisition of CombiMatrix, Becoming a Leader in Family and Reproductive Health Genetic Information Services (PR Newswire)
13.11.17	FDA Nod For BMY's Sprycel, ARNA To Report Data In Q1, MYL Delists From TASE (RTTNews)
06.11.17	Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017 (PR Newswire)
30.10.17	Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage (PR Newswire)
26.10.17	Safeguard Scientifics Announces Third Quarter 2017 Financial Results (PR Newswire)
24.10.17	Invitae to announce third quarter 2017 Financial Results and Host Conference Call on November 6, 2017 (PR Newswire)
17.10.17	Invitae data shows increased diagnosis rates with custom NGS technique allowing simultaneous genetic sequencing and copy number variant detection (PR Newswire)
05.10.17	Invitae's new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide (PR Newswire)
13.09.17	Invitae highlighting new research, expanded suite of services at National Society of Genetic Counselors (NSGC) 36th Annual Conference (PR Newswire)
13.09.17	Invitae to Present at the Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
29.08.17	Invitae to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference (PR Newswire)
28.08.17	LendingClub To Hold 2017 Investor Day (PR Newswire)
07.08.17	Invitae Reports Second Quarter 2017 Results (PR Newswire)
02.08.17	TrackR Closes $50M Dollars In Series B Funding Led By Revolution Growth (PR Newswire)
31.07.17	Safeguard Scientifics Partner Company Good Start Genetics To Be Acquired By Invitae Corporation (PR Newswire)
31.07.17	Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life (PR Newswire)
31.07.17	Invitae Announces $73.5 Million Private Placement Offering to Fuel Strategic Growth Opportunities and Reports Preliminary Second Quarter Financial Results (PR Newswire)
24.07.17	Invitae to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 7, 2017 (PR Newswire)
12.06.17	Invitae Acquires CancerGene Connect, Award-Winning Risk Assessment and Family History Analysis Platform (PR Newswire)
05.06.17	ASCO Data Shows Prostate Cancer Patients with Genetic Risk Factors Missed Under Current Testing Guidelines (PR Newswire)
25.05.17	Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand (PR Newswire)
12.05.17	Invitae to Present at the UBS Global Healthcare Conference (PR Newswire)
08.05.17	Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017 (PR Newswire)
28.04.17	New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing (PR Newswire)
24.04.17	Invitae to Announce First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017 (PR Newswire)
20.04.17	Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to confirm diagnoses... (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Invitae Corp

Aktien Top/Flop

Meistgelesene Nachrichten